AU Patent

AU2016385362B2 — Long acting injectable formulations

Assigned to Abon Pharmaceuticals LLC · Expires 2022-11-03 · 4y expired

What this patent protects

The invention relates to extended-release formulations comprising: (i) a poorly water-soluble active pharmaceutical ingredient; and (ii) a non-aqueous liquid vehicle comprising (a) a hydrophobic lipid comprising a glyceryl ester of a C

USPTO Abstract

The invention relates to extended-release formulations comprising: (i) a poorly water-soluble active pharmaceutical ingredient; and (ii) a non-aqueous liquid vehicle comprising (a) a hydrophobic lipid comprising a glyceryl ester of a C

Drugs covered by this patent

Patent Metadata

Patent number
AU2016385362B2
Jurisdiction
AU
Classification
—
Expires
2022-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Abon Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.